Form 8-K - Current report:
SEC Accession No. 0001213900-24-094344
Filing Date
2024-11-05
Accepted
2024-11-05 08:45:07
Documents
18
Period of Report
2024-11-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0219983-8k_adial.htm   iXBRL 8-K 32301
2 SEPARATION AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND JOSEPH TRULUCK, DAT ea021998301ex10-1_adial.htm EX-10.1 78951
3 EMPLOYMENT AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND VINAH SHAH, DATED N ea021998301ex10-2_adial.htm EX-10.2 161588
4 PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC ea021998301ex99-1_adial.htm EX-99.1 13279
5 GRAPHIC ex10-1_001.jpg GRAPHIC 4408
6 GRAPHIC ex99-1_001.jpg GRAPHIC 3998
  Complete submission text file 0001213900-24-094344.txt   547551

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE adil-20241101.xsd EX-101.SCH 3024
8 XBRL LABEL FILE adil-20241101_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE adil-20241101_pre.xml EX-101.PRE 22365
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0219983-8k_adial_htm.xml XML 3771
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 241425897
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)